
Accelerating Breakthrough Innovation
Our commitment to advancing health and life sciences is reflected in our two specialised investment funds. The 3xP Global Health Innovation Fund is dedicated to supporting breakthroughs in medical care, focusing on cutting-edge therapies and innovations that shape the future of healthcare.
Meanwhile, the 3xP Global Sustainable Innovation Fund addresses key challenges in energy efficiency and environmental sustainability, investing in advanced technologies that contribute to global efforts to reduce emissions and optimise resource use.
Our Commitment to Health and Life Sciences
The Sustainable Innovation Fund invests in cutting-edge companies excelling in technology and environmental advancements. Guided by the UN Principles for Responsible Investment (UN PRI), we focus on sectors like Biotechnology, Artificial Intelligence, Blockchain, and Nanotechnology.
Our goal is to support innovations that drive positive change and contribute to the UN Sustainable Development Goals (UN SDGs). Committed to integrating R&D with robust ESG practices, we promote a circular economy while delivering long-term value and resilience
Our Health Innovation Fund is dedicated to investing in tomorrow’s healthcare by leveraging opportunities within Portugal’s thriving CDMO market, which is pivotal to the biopharma industry due to its growing demand for specialised capabilities in biologics and advanced therapies.
Empowering the future of healthcare through cutting-edge biopharma innovation and specialised capabilities.
O Health Innovation, Fundo de Capital de Risco Fechado é co-financiado em 60% pelo Fundo de Capitalização e Resiliência (FdCR), gerido pelo Banco Português de Fomento, no âmbito do Programa Consolidar.
Saiba mais em bpfomento.pt/pt/prr/ e recuperarportugal.gov.pt.

Portugal’s Prime Position for Healthcare Innovation
Diversified Investment Strategy Beyond CDMO’s
30+ Years of Proven Expertise in Managing ESG Strategies
Lorem Ipsum has Been The Industry's
